Showing results (2031-2040 of 2,173) with videos related to
Sort By:
Pageof 218
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trialJean-Yves Douillard, Frances A Shepherd, Vera Hirsh, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 9, 2018
Metastatic breast cancer patients' expectations and priorities for symptom improvementDanielle B Tometich, Catherine E Mosher, Adam T Hirsh, et al.Journal of Structural Biology|August 31, 2023
A STRP-ed definition of Structured Tandem Repeats in ProteinsAlexander Miguel Monzon, Paula Nazarena Arrías, Arne Elofsson, et al.Science Translational Medicine|May 19, 2017
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failureQiming Duan, Sarah McMahon, Priti Anand, et al.Pacing and Clinical Electrophysiology : PACE|February 23, 2017
Clinical Performance of Magnetic Resonance Imaging Conditional and Nonconditional Cardiac Implantable Electronic DevicesAnand D Shah, Adarsh U Patel, Andrea Knezevic, et al.International Journal of Cancer|April 19, 2018
Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancerLinnéa La Fleur, Vanessa F Boura, Andrey Alexeyenko, et al.Annals of Surgery|April 29, 2021
Prevention of Firearm Violence Through Specific Types of Community-based Programming: An Eastern Association for the Surgery of Trauma Evidence-based ReviewStephanie L Bonne, Pina Violano, Thomas K Duncan, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 16, 2004
Two interdependent TRPV channel subunits, inactive and Nanchung, mediate hearing in DrosophilaZhefeng Gong, Wonseok Son, Yun Doo Chung, et al.Clinical Lung Cancer|July 22, 2017
Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based ChemotherapyEnriqueta Felip, Vera Hirsh, Sanjay Popat, et al.BMC Cancer|August 7, 2016
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancerJohanna S M Mattsson, Hans Brunnström, Verena Jabs, et al.Pageof 218